Recipharm commences new supply contract and completes purchase of facility in Spain

pharmafile | December 4, 2017 | News story | Manufacturing and Production Recipharm 

Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of the manufacturing facility located in Leganés, Spain.

Thomas Eldered, CEO of Recipharm commented: “We are continuing to gain momentum in the CDMO market and this latest agreement is another demonstration of this. I welcome our new colleagues in Spain and look forward to providing Roche with first-class CDMO services”. 

Contact information
Thomas Eldered, CEO, telephone: +46 8 602 52 10
Henrik Stenqvist, CFO,, telephone: +46 8 602 52 00

This information is information that Recipharm AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 1 December 2017, at 13:00 CET. 

Related Content

Recipharm equips a further three facilities for US serialisation

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its …

Recipharm Interim report January – September 2017

Interim report January – September 2017 July – September 2017    

Recipharm to end operations in two facilities in Sweden

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing …

Latest content